Ready to invest in U.S. manufacturing?
In today’s landscape of tariffs, regulatory shifts, and supply chain fragility, having pharmaceutical manufacturing anchored in the U.S. isn’t optional—it’s essential. Bora offers reliable, U.S.-centered manufacturing with regulatory readiness, proven expertise across oral solids, liquids, powders, biologics, and sterile injectables.
Bora U.S. facilities
Baltimore–Camden, MD Facility
Sterile Injectable Fill/Finish Hub
- 87,000 sq. ft. facility
- Four aseptic fill/finish lines
- Lyophilization, vials, pre-filled syringes
- Packaging, labeling, and inspection
- On-site formulation and testing
Maple Grove, MN Facility
Oral Solid Dose, Powders & Liquids Hub
- 100,000 sq. ft. of customizable capacity
- High-throughput oral solid dose manufacturing
- Expertise in solvent handling and DEA-controlled drugs
- On-site development labs and QC capabilities
- Located in Medical Alley, the epicenter of U.S. health innovation
San Diego, CA Facility
Biologics Drug Substance Hub
- Development through commercialization with Bora Biologics site in San Diego
- Integration with Baltimore sterile fill/finish for seamless biologics scale-up
- End-to-end biologics expertise, from formulation to delivery systems
